Modulation by interleukin-4 of cytokine release from mononuclear phagocytes in asthma.

[1]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[2]  J. Bousquet,et al.  Airway macrophages from patients with asthma do not proliferate. , 1993, The Journal of allergy and clinical immunology.

[3]  J. Bousquet,et al.  Increased expression of adhesion molecules (ICAM‐1 and LFA‐1) on alveolar macrophages from asthmatic patients , 1993, Allergy.

[4]  L. Schook,et al.  Erratum: Tumor necrosis factor α is an autocrine growth regulator during macrophage differentiation (Proc. Natl. Acad. Sci. USA (May 1992) 89 (4754- 4758)) , 1993 .

[5]  J. Dayer,et al.  Regulation of Interleukin-1ra, Interleukin-1α, and Interleukin-1β Production by Human Alveolar Macrophages with Phorbol Myristate Acetate, Lipopolysaccharide, and Interleukin-4 , 1993 .

[6]  P. Howarth,et al.  Interleukin 4 is localized to and released by human mast cells , 1992, The Journal of experimental medicine.

[7]  A. Capron,et al.  Tumor necrosis factor alpha and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. , 1992, The American review of respiratory disease.

[8]  M. Wadhwa,et al.  Detection and measurement of cytokines. , 1992, Blood reviews.

[9]  H. Hoogsteden,et al.  Regulation of aminopeptidase-N (CD13) and Fc epsilon RIIb (CD23) expression by IL-4 depends on the stage of maturation of monocytes/macrophages. , 1992, Journal of immunology.

[10]  G. Hunninghake,et al.  Alveolar macrophages have greater amounts of the enzyme 5-lipoxygenase than do monocytes. , 1992, Journal of applied physiology.

[11]  S. Sone,et al.  Differential effects of interleukin‐4 on superoxide anion production by human alveolar macrophages stimulated with lipopolysaccharide and interferon‐γ , 1992, Journal of leukocyte biology.

[12]  J. Dayer,et al.  Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. , 1992, The Journal of clinical investigation.

[13]  C. Stewart,et al.  Inhibitory role of interleukin‐6 in macrophage proliferation , 1992, Journal of leukocyte biology.

[14]  L B Schook,et al.  Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Bousquet,et al.  Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. , 1992, The American review of respiratory disease.

[16]  M. Lotze,et al.  Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes. , 1992, Journal of immunology.

[17]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[18]  J. Wijdenes,et al.  IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. , 1991, Journal of immunology.

[19]  K. Tanaka,et al.  Interleukin‐4 Downregulates Interleukin‐6 Production by Human Alveolar Macrophages at Protein and mRNA Levels , 1991, Microbiology and immunology.

[20]  A. Capron,et al.  Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. , 1991, The Journal of allergy and clinical immunology.

[21]  S. Durham,et al.  Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. , 1991, The Journal of allergy and clinical immunology.

[22]  J. Bousquet,et al.  Increased numbers of hypodense alveolar macrophages in patients with bronchial asthma. , 1991, The American review of respiratory disease.

[23]  R. Sergysels,et al.  Domestic endotoxin exposure and clinical severity of asthma , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[24]  J. Elias,et al.  Human alveolar macrophage and blood monocyte interleukin-6 production. , 1990, American journal of respiratory cell and molecular biology.

[25]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[26]  J. Pujol,et al.  Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. , 1990, International archives of allergy and applied immunology.

[27]  A. Wardlaw,et al.  Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. , 1989, The American review of respiratory disease.

[28]  J. Pujol,et al.  Identification of an alveolar macrophage-derived activity in bronchial asthma that enhances leukotriene C4 generation by human eosinophils stimulated by ionophore A23187 as a granulocyte-macrophage colony-stimulating factor. , 1989, The American review of respiratory disease.

[29]  M. Wewers,et al.  Alveolar macrophages differ from blood monocytes in human IL-1 beta release. Quantitation by enzyme-linked immunoassay. , 1989, Journal of immunology.

[30]  D. Morton,et al.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. , 1989, Journal of immunology.

[31]  P. Hart,et al.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Rankin,et al.  The contribution of alveolar macrophages to hyperreactive airway disease. , 1989, The Journal of allergy and clinical immunology.

[33]  J. Vilček,et al.  Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[34]  M. Peters-Golden,et al.  Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects. , 1988, The American review of respiratory disease.

[35]  K. Arai,et al.  IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Capron,et al.  Production of an interleukin-1 inhibitory factor by human alveolar macrophages from normals and allergic asthmatic patients. , 1988, The American review of respiratory disease.

[37]  S. Haskill,et al.  Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. , 1988, Journal of immunology.

[38]  C. Figdor,et al.  Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. , 1988, Journal of immunology.

[39]  A. Brody,et al.  Stimulation of arachidonic acid metabolism by adherence of alveolar macrophages to a plastic substrate. Modulation by fetal bovine serum. , 1988, The American review of respiratory disease.

[40]  J. Bousquet,et al.  Enhanced alveolar cell luminol-dependent chemiluminescence in asthma. , 1987, The Journal of allergy and clinical immunology.

[41]  T. Ferro,et al.  Differential Prostaglandin Production by Unfractionated and Density‐Fractionated Human Monocytes and Alveolar Macrophages , 1987, Journal of leukocyte biology.

[42]  C. Chavis,et al.  Arachidonic acid metabolism in alveolar macrophages. A comparison of cells from healthy subjects, allergic asthmatics, and chronic bronchitis patients. , 1987, Prostaglandins.

[43]  A. Capron,et al.  Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics. , 1987, Bulletin europeen de physiopathologie respiratoire.

[44]  T. Ferro,et al.  Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen. , 1987, The American review of respiratory disease.

[45]  J. Vilček,et al.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[46]  R. Coffman,et al.  T-cell and mast cell lines respond to B-cell stimulatory factor 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[47]  H. Shepard,et al.  Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Capron,et al.  Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. , 1983, The Journal of clinical investigation.

[49]  P. Askenase,et al.  IgE-dependent release of leukotriene C4 from alveolar macrophages , 1982, Nature.

[50]  K Aas,et al.  Heterogeneity of Bronchial Asthma , 1981, Allergy.

[51]  A. Capron,et al.  Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E. , 1980, Clinical and experimental immunology.

[52]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .